AI assistant
Adaptive Biotechnologies Corp — Director's Dealing 2019
Jun 27, 2019
31660_dirs_2019-06-26_2336b43c-8017-4828-8acb-7c2f526d78b0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2019-06-26
Reporting Person: PISKEL KYLE (Corporate Controller)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $6.32 | 2025-09-15 | Common Stock (20000) | Direct | |
| Stock Option (Right to Buy) | $6.32 | 2026-11-08 | Common Stock (10000) | Direct | |
| Stock Option (Right to Buy) | $6.55 | 2028-10-01 | Common Stock (25000) | Direct | |
| Stock Option (Right to Buy) | $7.8 | 2029-04-23 | Common Stock (5000) | Direct |
Footnotes
F1: The options vested with respect to 1/4 of such shares on September 1, 2016, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F2: The options vested with respect to 1/4 of such shares on October 1, 2017, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F3: The options vest with respect to 1/4 of such shares on October 1, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F4: The options vest with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.